{
    "root": "9dbf7d7f-f886-43ff-be3c-b09ec6310ae7",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Avapro",
    "value": "20250225",
    "ingredients": [
        {
            "name": "IRBESARTAN",
            "code": "J0E2756Z7N"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "HYPROMELLOSE, UNSPECIFIED",
            "code": "3NXW29V3WO"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "POLYETHYLENE GLYCOL 3000",
            "code": "SA1B764746"
        },
        {
            "name": "CARNAUBA WAX",
            "code": "R12CBM0EIZ"
        }
    ],
    "indications": "avapro angiotensin ii receptor blocker ( arb ) indicated : treatment hypertension , lower blood pressure . lowering blood pressure reduces risk fatal nonfatal cardiovascular events , primarily strokes myocardial infarctions . ( 1.1 ) treatment diabetic nephropathy hypertensive patients type 2 diabetes , elevated serum creatinine , proteinuria . ( 1.2 )",
    "contraindications": "indication dose hypertension ( 2.2 ) 150 300 mg daily diabetic nephropathy ( 2.3 ) 300 mg daily",
    "warningsAndPrecautions": "avapro ( irbesartan ) available white off-white , biconvex oval , film-coated tablets , debossed heart shape one side code ( table ) . unit-of-use bottles contain 30 90 film-coated tablets follows : 75 mg 150 mg 300 mg debossing 2871 2872 2873 bottle 30 \u2013 0024-5851-30 0024-5852-30 bottle 90 0024-5850-90 \u2013 \u2013",
    "adverseReactions": "avapro contraindicated patients hypersensitive component product . coadminister aliskiren avapro patients diabetes .",
    "indications_original": "AVAPRO is an angiotensin II receptor blocker (ARB) indicated for: Treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. ( 1.1 ) Treatment of diabetic nephropathy in hypertensive patients with type 2 diabetes, an elevated serum creatinine, and proteinuria. ( 1.2 )",
    "contraindications_original": "Indication Dose Hypertension ( 2.2 ) 150 to 300 mg once daily Diabetic Nephropathy ( 2.3 ) 300 mg once daily",
    "warningsAndPrecautions_original": "AVAPRO (irbesartan) is available as white to off-white, biconvex oval, film-coated tablets, debossed with a heart shape on one side and a code on the other (see Table below). Unit-of-use bottles contain 30 or 90 film-coated tablets as follows: \n                  \n                     \n                     \n                     \n                     \n                     \n                        \n                           \n                           75 mg\n                           150 mg\n                           300 mg\n                        \n                     \n                     \n                        \n                           Debossing\n                           2871\n                           2872\n                           2873\n                        \n                        \n                           Bottle of 30\n                           \u2013\n                           0024-5851-30\n                           0024-5852-30\n                        \n                        \n                           Bottle of 90\n                           0024-5850-90\n                           \u2013\n                           \u2013",
    "adverseReactions_original": "AVAPRO is contraindicated in patients who are hypersensitive to any component of this product.\n                  Do not coadminister aliskiren with AVAPRO in patients with diabetes."
}